載入...
CD150(−) side population defines leukemia stem cells in a BALB/C mouse model of CML and is depleted by genetic loss of SIRT1
Leukemia stem cells (LSCs) of chronic myeloid leukemia (CML) are refractory to tyrosine kinase inhibitor treatment, persist in the residual disease and are important source for disease recurrence. Better understanding CML LSCs will help devise new strategies to eradicate these cells. The BALB/c mous...
Na minha lista:
| 發表在: | Stem Cells |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4713280/ https://ncbi.nlm.nih.gov/pubmed/26466808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.2218 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|